文献速递糖尿病肥胖与代谢综合征

2型糖尿病进展的靶向与非靶向代谢组学整合分析

Integrative Metabolomics of Targeted and Nontargeted Analyses in T2D Progression.
PubMed 文献 · Diabetes Care · 2026-01-01

基于KORA队列8,240次观测、104种靶向和312种非靶向代谢物,分析正常糖代谢向糖尿病前期及2型糖尿病进展的代谢轨迹。发现140种Bonferroni显著代谢物,早期以能量代谢标志物为主,晚期以氨基酸改变为主;空腹血糖介导了γ-谷氨酰缬氨酸与T2D关联的35.1%,孟德尔随机化未发现C2、BCAAs或γ-谷氨酰缬氨酸的因果作用。

要点

  • 能量代谢标志物(脂肪酸氧化、TCA循环)在糖尿病前期阶段即出现改变。
  • 支链氨基酸和γ-谷氨酰衍生物等氨基酸改变出现在较晚阶段。
  • 空腹血糖部分介导γ-谷氨酰缬氨酸与T2D的关联,但孟德尔随机化未支持因果性。

核心结论

  • 能量代谢转变发生在糖尿病进展早期,氨基酸改变出现于较晚阶段。
  • 这些阶段特异性代谢特征可能指导糖尿病预防策略。

研究设计与样本

  • 研究分析KORA队列8,240次观测,覆盖基线(S4)及随访(F4和FF4)共14年。
  • 检测104种靶向代谢物和312种非靶向代谢物。
  • 轨迹分析纳入1,050人,识别211例新发糖尿病前期和112例新发2型糖尿病。
  • 采用线性混合效应模型(基础模型调整年龄、性别、BMI、生活方式;敏感性模型额外调整空腹血糖等血糖因素及收缩压等心血管因素)。
  • 运用中介分析和孟德尔随机化分析探讨机制与因果关联。

主要发现

  • 共识别140种Bonferroni显著代谢物(45种靶向、109种非靶向、14种重叠)。
  • 68种早期阶段代谢物在糖尿病前期或2型糖尿病对比正常糖代谢时显著,主要为脂肪酸氧化代谢物(如37种脂质)和三羧酸循环代谢物(如柠檬酸)。
  • 在新发病例中观察到较少的显著关联;敏感性模型验证了50%的早期阶段代谢物,但未验证晚期阶段代谢物。
  • 空腹血糖介导了γ-谷氨酰缬氨酸与2型糖尿病关联的35.1%。

临床怎么用

  • 能量代谢标志物可在糖尿病前期阶段用于风险分层,氨基酸标志物更适用于进展后期监测。
  • 空腹血糖部分介导γ-谷氨酰缬氨酸与T2D关联,提示血糖控制可能影响该代谢通路。
  • 孟德尔随机化未支持C2、BCAAs或γ-谷氨酰缬氨酸的因果作用,暂不宜作为干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to identify metabolites characterizing the progression from normal glucose metabolism (NORM) to prediabetes (PreT2D) and type 2 diabetes (T2D), focusing on stage-specific metabolic shifts (early: NORM to PreT2D; late: PreT2D to T2D) and mechanistic relevance. RESEARCH DESIGN AND METHODS: We analyzed 8,240 observations from the KORA cohort, profiling 104 targeted and 312 nontargeted metabolites across three time points: baseline (S4) and follow-ups (F4 and FF4) spanning 14 years. Trajectory analyses of 1,050 individuals identified 211 incident PreT2D and 112 incident T2D cases. Linear mixed-effects models (basic: adjusted for age, sex, BMI, lifestyle; sensitivity: additionally adjusted for glycemic factors like fasting glucose, and cardiovascular factors such as systolic blood pressure (BP) were used to evaluate metabolic differences across glycemic states. Mediation and Mendelian randomization (MR) analyses examined mechanistic and causal relationships. RESULTS: We identified 140 Bonferroni-significant metabolites (45 targeted, 109 nontargeted, 14 overlapping), including 68 early-stage metabolites (significant in PreT2D/T2D vs. NORM), primarily energy metabolism markers such as fatty acid oxidation metabolites (e.g., 37 lipids) and tricarboxylic acid cycle metabolites (e.g., citrate). Twenty late-stage metabolites (significant in T2D vs. PreT2D/NORM) included amino acids like branched-chain amino acids (BCAAs) and γ-glutamyl derivatives. Fewer significant associations were observed in incident cases. Sensitivity models validated 50% of early-stage but not late-stage metabolites. Fasting glucose mediated 35.1% of the γ-glutamyl-valine-T2D association, while MR analysis found no causal roles for C2, BCAAs, or γ-glutamyl-valine. CONCLUSIONS: Energy metabolism shifts occur early, while amino acid alterations emerge later stages. These stage-specific signatures may guide diabetes prevention strategies.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Ge J, Han S, Shi M, et al. Integrative Metabolomics of Targeted and Nontargeted Analyses in T2D Progression. Diabetes Care. 2026. PMID: 41335123. doi:10.2337/dc25-1707

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。